Baird Financial Group’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
SSM
DRZID
Baird Financial Group's OGN Position: Q1 2025 in Review
Baird Financial Group sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 23,929 shares — an estimated $357K sold.
Baird Financial Group first reported a position in OGN in Q2 2021 and held it in 15 quarters. The position peaked at $12.1M in Q4 2022. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.
- Baird Financial Group reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
- Baird Financial Group sold 23,929 Organon & Co shares in Q1 2025, an estimated $357K.
- Baird Financial Group first reported a position in Organon & Co in Q2 2021 and held it in 15 quarters.
- Baird Financial Group's Organon & Co position peaked at $12.1M in Q4 2022.
- 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.
Based on Baird Financial Group's 13F filing for Q1 2025, filed 15 May 2025.